Text Size
428 studies found for:    "Abdominal Neoplasms"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Determination of a Safe Dose of Optison in Pediatric Patients With Solid Tumors
Conditions: Abdominal Neoplasms;   Pelvic Neoplasms
Intervention: Drug: Optison
2 Completed Restricted Intravenous Fluid Regime Effects on Immunological Indicators of Elderly Patients Operated for Abdominal Cancer
Conditions: Surgery;   Perioperative Care;   Immunization;   Abdominal Neoplasms
Interventions: Behavioral: perioperative fluid management;   Behavioral: perioperative fluid treatment
3 Completed Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer Surgery
Condition: Abdominal Neoplasms
Interventions: Drug: enoxaparin;   Other: Physical prophylaxis
4 Completed
Has Results 		Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy
Conditions: Abdominal Neoplasm;   Colonic Neoplasm;   Mesothelioma;   Peritoneal Neoplasm
Interventions: Procedure: Surgery;   Procedure: Continuous hyperthermic peritoneal perfusion (CHPP) with Cisplatin;   Drug: Postoperative dwell with paclitaxel and 5-FU
5 Recruiting Comparison the Hemodynamics Effects Between Dexmedetomidine and Propofol in Major Abdominal Surgical Patients
Conditions: Abdominal Tumor;   Intestinal Obstruction;   Cirrhosis;   Intestinal Fistula;   Aneurism
Interventions: Drug: dexmedetomidine;   Drug: propofol
6 Recruiting Evaluation of Respiratory Motion-Corrected Cone-Beam CT in Radiation Treatment of Thoracic and Abdominal Cancers
Conditions: Gastric Cancer;   Lung Cancer
Intervention: Procedure: respiration correlated CT scan
7 Completed
Has Results 		Effects of Rocking on Postoperative Ileus Duration Study
Condition: Abdominal Cancer
Intervention: Other: Rocking Chair Intervention
8 Completed Investigating the Improvement in 4D CT Images Using AV Biofeedback
Conditions: Cancer of the Lung;   Abdominal Cancer
Intervention:
9 Completed Respiratory Tumor and Normal Tissue Motion
Conditions: Lung Cancer;   Abdominal Cancer
Intervention: Procedure: Motion CT Scans
10 Active, not recruiting A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Conditions: Abdominal Cancer;   Pelvic Cancer
Intervention: Other: Cardiopulmonary Exercise Testing (CPET)
11 Completed Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Primary Peritoneal Cavity Cancer
Interventions: Biological: filgrastim;   Drug: carboplatin;   Drug: cyclophosphamide;   Procedure: autologous bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation
12 Completed EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer
Conditions: Ovarian Neoplasms;   Peritoneal Neoplasms;   Fallopian Tube Neoplasms
Intervention: Drug: epothilone b
13 Suspended
Has Results 		Sorafenib With or Without Paclitaxel and Carboplatin in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Conditions: Recurrent Fallopian Tube Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Primary Peritoneal Cavity Cancer
Interventions: Drug: sorafenib tosylate;   Drug: paclitaxel;   Drug: carboplatin
14 Completed Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer
Conditions: Fallopian Tube Cancer;   Infection;   Neutropenia;   Ovarian Cancer;   Primary Peritoneal Cavity Cancer
Interventions: Biological: pegfilgrastim;   Drug: carboplatin;   Drug: paclitaxel;   Procedure: adjuvant therapy
15 Recruiting Safety Study Involving Oxaliplatin With Docetaxel for Recurrent Ovarian,Primary Peritoneal, and Fallopian Tube Cancer
Conditions: Ovarian Cancer;   Peritoneal Cancer;   Fallopian Tube Cancer
Interventions: Drug: intravenous docetaxel with intraperitoneal oxaliplatin;   Drug: intravenous oxaliplatin with intraperitoneal docetaxel
16 Terminated Vorinostat, Carboplatin and Gemcitabine Plus Vorinostat Maintenance in Women With Recurrent, Platinum-Sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer;   Peritoneal Cancer
Interventions: Drug: Vorinostat;   Device: Carboplatin;   Drug: Gemcitabine
17 Completed Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Conditions: Ovarian Cancer;   Peritoneal Neoplasms;   Fallopian Tube Neoplasms
Interventions: Biological: Cetuximab:;   Drug: Paclitaxel;   Drug: Carboplatin
18 Terminated
Has Results 		Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer
Interventions: Drug: capecitabine;   Drug: docetaxel
19 Completed VEGF Trap and Docetaxel in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Conditions: Fallopian Tube Cancer;   Primary Peritoneal Cavity Cancer;   Recurrent Ovarian Epithelial Cancer
Interventions: Drug: docetaxel;   Biological: ziv-aflibercept;   Other: laboratory biomarker analysis;   Other: pharmacological study
20 Terminated Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second Remission
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Primary Peritoneal Cavity Cancer
Interventions: Drug: sorafenib tosylate;   Other: immunoenzyme technique;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: pharmacological study
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years